Daming Ou
Impact in
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Sirtuins and Resveratrol in Medicine
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 1
- Fibroblast Growth Factor Research 1
- Circular RNAs in diseases 1
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 1
- Lung Cancer Treatments and Mutations 1
- Co-authors
- Ting Liu (2 shared papers)Ji Zhang (2 shared papers)Jing Liu (2 shared papers)Guanmin Jiang (1 shared paper)Xu Han (1 shared paper)Honglin Huang (2 shared papers)Junhua Liu (1 shared paper)Honglin Huang (1 shared paper)
- Journals
- Applied Microbiology and Biotechnology (1 paper)Journal of Cellular Physiology (1 paper)PubMed (5 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Daming Ou
7 papers receiving 525 citations
Daming Ou's Hit Papers
Peers
Comparison fields: 5 of 84
- Cancer Research 135
- Geriatrics and Gerontology 24
- Epidemiology 201
- Physiology 22
- Molecular Biology 315
Countries citing papers authored by Daming Ou
This map shows the geographic impact of Daming Ou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daming Ou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daming Ou more than expected).
Fields of papers citing papers by Daming Ou
This network shows the impact of papers produced by Daming Ou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daming Ou. The network helps show where Daming Ou may publish in the future.
Co-authors
The 16 scholars most cited alongside Daming Ou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Targeting PI3K/AKT/mTOR-mediated autophagy for tumor therapy Hit paper breakdown → | 2019 | 456 |
| 2 | 2018 | 42 | |
| 3 | Endothelin-1, an important mitogen of smooth muscle cells of spontaneously hypertensive rats. | 2002 | 9 |
| 4 | Probucol inhibits lipid peroxidation of macrophage and affects its secretory properties. | 2000 | 9 |
| 5 | Probucol inhibits oxidized-low density lipoprotein-induced adhesion of monocytes to endothelial cells in vitro. | 2002 | 7 |
| 6 | [CALM-AF10 fusion transcripts in primary leukemia with t(10;11) and in vitro chemotherapy sensitivity of leukemic cells with t(10;11)]. | 2004 | 2 |
| 7 | 2020 | 2 |
About Daming Ou
Daming Ou is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Genetics, Epidemiology and Public Health, Environmental and Occupational Health, having authored 7 papers that have together received 527 indexed citations. Recurring topics across this work include Atherosclerosis and Cardiovascular Diseases (1 paper), MicroRNA in disease regulation (1 paper), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (1 paper), Cancer-related molecular mechanisms research (1 paper), PI3K/AKT/mTOR signaling in cancer (1 paper), Lung Cancer Treatments and Mutations (1 paper), Fibroblast Growth Factor Research (1 paper) and Circular RNAs in diseases (1 paper). The work is most often cited by research in Cancer Research (135 citations), Geriatrics and Gerontology (24 citations), Epidemiology (201 citations), Physiology (22 citations) and Molecular Biology (315 citations). Daming Ou has collaborated with scholars based in China and United States. Frequent co-authors include Ting Liu, Ji Zhang, Jing Liu, Guanmin Jiang, Xu Han, Honglin Huang, Junhua Liu, Honglin Huang, Duan‐Fang Liao and Hua Wang. Their work appears in journals such as Applied Microbiology and Biotechnology, Journal of Cellular Physiology and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.